Inactive Instrument

Company Cell MedX Corp OTC Bulletin Board

Equities

US15115X1072

Biotechnology & Medical Research

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Cell MedX Corp

Business Summary

Cell MedX Corp. is a biotechnology company. It is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, general health, pain relief, wellness and alleviate complications associated with medical conditions including, diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney function. The Company, through its subsidiary, is engaged in developing and manufacturing therapeutic devices based on its eBalance technology, which harnesses the power of microcurrents and its effects on the human body. The eBalance Pro System and eBalance Home System, are microcurrent electrotherapy systems intended to administer a specific variety of therapeutic microcurrent algorithms for temporary relief of pain associated with sore/aching muscles in the shoulders, waist, back, neck, upper extremities (arms) and lower extremities. Its Microcurrent therapy uses molecular bioelectricity in cell-to-cell signaling.

Sales per Business

USD in Million2022Weight2023Weight Delta
Monthly Subscriptions
58.8 %
0 60.6 % 0 58.8 % -55.85%
eBalance Devices
41.2 %
0 39.4 % 0 41.2 % -52.33%

Sales per region

USD in Million2022Weight2023Weight Delta
Canada
100.0 %
0 100.0 % 0 100.0 % -54.46%

Managers

Managers TitleAgeSince
Chief Executive Officer 54 Dec. 11
Director of Finance/CFO 45 14-11-23
Chairman 76 18-03-22
Director/Board Member 59 20-06-07
Director/Board Member 63 22-04-26

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 54 Dec. 11
Director/Board Member 63 22-04-26
Director/Board Member 59 20-06-07
Chairman 76 18-03-22
Director/Board Member 55 Dec. 11
Director of Finance/CFO 45 14-11-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 297,236,373 60,447,694 ( 20.34 %) 0 20.34 %

Shareholders

NameEquities%Valuation
88,959,726 30.18 % 3 M $
64,855,148 22.00 % 2 M $
25,639,897 8.699 % 769 197 $
Clementine Tang
8.357 %
24,631,939 8.357 % 738 958 $
Sam Ahdoot
8.156 %
24,039,142 8.156 % 721 174 $
5,341,855 1.812 % 160 256 $
2,056,687 0.6978 % 61 701 $
1,214,285 0.4120 % 36 429 $
50,000 0.0170 % 1 500 $

Company contact information

Cell MedX Corp.

820 - 1130 Pender Street

V6E 4A4, West Vancouver

+844 238 2692

http://www.cellmedx.com
address Cell MedX Corp